
The mechanisms responsible of either a loss of therapeutic efficiency or a beneficial cancellation of toxic phenomena are reviewed. References are specifically made to antagonists of anti-vitamin K, oral contraceptives, antihypertensive drugs and statin. Concerning the antidotes, the importance of anti-digoxin antibodies, naloxone and flumazenil is emphasised.
Anticholesteremic Agents, Antidotes, Anticoagulants, Humans, Drug Antagonism, Antihypertensive Agents
Anticholesteremic Agents, Antidotes, Anticoagulants, Humans, Drug Antagonism, Antihypertensive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
